bioengineer.org
/1 week ago
ALDH2 Suppresses Multiple Myeloma Progression by Restraining the E2F Signaling Pathway
Researchers found that ALDH2 acts as an independent favorable prognostic biomarker in multiple myeloma, curbing cancer cell proliferation and promoting apoptosis through suppressio...